These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 5762300)
41. Oral contraceptives and cervical cancer. A preliminary report of an experimental study. Myhre E; Bjoro K Acta Pathol Microbiol Scand; 1969; 76(3):495-6. PubMed ID: 5823365 [No Abstract] [Full Text] [Related]
42. Oral progestational agents: therapy and complications. Orr GW S D J Med; 1969 Jan; 22(1):11-7. PubMed ID: 5250065 [No Abstract] [Full Text] [Related]
43. [The psychiatrist and the pill. Study of the psychiatric repercussions of oral contraception]. Bourgeois M; Hébert A; Emperaire JC Ann Med Psychol (Paris); 1971 Jul; 2(2):279-98. PubMed ID: 5123115 [No Abstract] [Full Text] [Related]
44. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens. van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435 [TBL] [Abstract][Full Text] [Related]
46. [Pseudogravidic psychoneuroses caused by gestagens]. La Gravinese N Policlinico Prat; 1965 Nov; 72(48):1639-44. PubMed ID: 5867637 [No Abstract] [Full Text] [Related]
47. More contraindications to the pill. Realini JP Pediatrics; 1980 Oct; 66(4):644-5. PubMed ID: 7432859 [No Abstract] [Full Text] [Related]
48. Breast cancer and oral contraceptives: critique of the proposition that high potency progestogen products confer excess risk. Sturtevant FM Biomed Pharmacother; 1984; 38(8):371-9. PubMed ID: 6525434 [TBL] [Abstract][Full Text] [Related]
49. [Differences in the activity of gestagens. The effects of gestagens in the pill on skin, hair and body weight]. Krankenpfl J; 1998 Jan; 36(1):25. PubMed ID: 9536698 [No Abstract] [Full Text] [Related]
50. Oral contraceptives and the risk of cardiovascular disease. Med Lett Drugs Ther; 1983 Jul; 25(640):69-70. PubMed ID: 6865850 [TBL] [Abstract][Full Text] [Related]
51. [Exogenous estrogens and carcinoma of the endometrium: a critical analysis of the literature]. Franceschi S; La Vecchia C Ann Ostet Ginecol Med Perinat; 1980; 101(6):397-403. PubMed ID: 7008676 [No Abstract] [Full Text] [Related]
52. The pill, breast and cervical cancer, and the role of progestogens in arterial disease. Lincoln R Fam Plann Perspect; 1984; 16(2):55-63. PubMed ID: 6373360 [No Abstract] [Full Text] [Related]
53. [A serial method for ovulation inhibition using ethinyl estradiol]. McBride WG Arzneimittelforschung; 1969 Aug; 19(8):1271-3. PubMed ID: 5820291 [No Abstract] [Full Text] [Related]
54. [The benefit of the classification of oral contraceptives. Studies of 525 women taking oral contraceptives (author's transl)]. Wenderlein JM MMW Munch Med Wochenschr; 1981 Jun; 123(23):957-61. PubMed ID: 6789156 [TBL] [Abstract][Full Text] [Related]
55. [Psychopathological complications due to oral contraception]. Mélon J Rev Med Liege; 1972 Jun; 27(11):362-5. PubMed ID: 4557417 [No Abstract] [Full Text] [Related]
56. Mood and the "pill". West J Br Med J; 1968 Oct; 4(5624):187-8. PubMed ID: 5681062 [No Abstract] [Full Text] [Related]
57. Bibliographies on diseases of medical progress. Disorders produced by progestational agents. Moser RH Clin Pharmacol Ther; 1966; 7(3):399-410. PubMed ID: 5327857 [No Abstract] [Full Text] [Related]
58. [The effect of ovulation inhibitors on the vaginal picture and the portio epithelium]. Mehring W Med Klin; 1965 Dec; 60(50):2016-7. PubMed ID: 5870226 [No Abstract] [Full Text] [Related]